Symbio is a client-focused international full-service CRO, specialized in Dermatology.
We manage all CRO core services in-house and have our offices in the US and Europe. Since 2002 we deliver excellent service and provide experienced qualified personnel to strategically manage all aspects of clinical trials as well as support biotech and pharma companies with the clinical development programm planning.

Symbio offers expertise in Phase I – IV drug, medical device and cosmetics research studies and has completed over 130 projects to date around the globe.
Also, in conjunction with Dow Development Laboratories, LLC, Symbio’s subsidiary, we offer a turnkey CRO solution that also includes design, development and formulation of topical products.

Our clients benefit from our team’s broad experience and extensive industry network and receive operational, regulatory and scientific support during the whole product development process.